Fusen Pharmaceutical Company Ltd (1652)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 22 Oct 2026
Key indicators
| Last close | HKD 0.790 |
|---|---|
| 52-week range | 0.640 – 1.440 |
| Return, 1 month / 3 months | +4.6% / −29.5% |
| Return, 1 year / 3 years | +11.3% / −47.3% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 74.4% |
| Worst drawdown (1 year) | -46.8% |
| Average daily value traded | 0.08M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Fusen Pharmaceutical Company Ltd (1652) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 0.790 on 22 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 1,833 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.3% and over the last three months it fell 29.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -20.6% | ||
| From 52-week high | -43.2% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -29.5% | ||
| 6-month return | -35.2% | ||
| 12-month return, skipping the last month | 6.3% | ||
| Stability (higher is calmer) | 42 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 74.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.8% | ||
| Liquidity | 33 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.08M HKD | ||
| Zero-volume days | 16.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −8.7% |
|---|---|
| 1 month | +4.6% |
| 3 months | −29.5% |
| 6 months | −35.2% |
| 1 year | +11.3% |
| 3 years | −47.3% |
| 5 years | −69.9% |
Signals
| 50-day / 200-day average | 0.875 / 0.995 |
|---|---|
| Golden / death cross (60 days) | Death, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.059 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jun 2022 | HKD 0.0042 |
| 17 Sep 2021 | HKD 0.0068 |
| 8 Jun 2021 | HKD 0.0054 |
| 15 Sep 2020 | HKD 0.0051 |
| 3 Jul 2020 | HKD 0.0040 |
| 13 Sep 2019 | HKD 0.0033 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.